We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Primary Health Properties Plc | LSE:PHP | London | Ordinary Share | GB00BYRJ5J14 | ORD 12.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 93.00 | 92.95 | 93.00 | 94.15 | 92.30 | 94.15 | 8,485,942 | 16:29:33 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Real Estate Agents & Mgrs | 169.8M | 27.3M | 0.0204 | 45.59 | 1.24B |
TIDMPHP
RNS Number : 6250A
Primary Health Properties PLC
27 March 2017
27 March 2017
Primary Health Properties PLC
In accordance with Listing Rule 9.6.14(2), Primary Health Properties PLC (the "Company") announces that Mr Harry Hyman, Managing Director of the Company, has been appointed as a Non-Executive Director of Biopharma Credit PLC whose shares were listed on the London Stock Exchange's Main Market today.
Further details:
Paul Wright, Nexus Management Services Limited, Company Secretary 020 7451 7050
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDNJRMBTMBMTBMR
(END) Dow Jones Newswires
March 27, 2017 07:01 ET (11:01 GMT)
1 Year Primary Health Properties Chart |
1 Month Primary Health Properties Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions